HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 215 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,877,000 | -3.7% | 150,220 | 0.0% | 0.58% | -16.3% |
Q2 2020 | $4,027,000 | +49.0% | 150,220 | 0.0% | 0.70% | +31.2% |
Q1 2020 | $2,702,000 | +1.6% | 150,220 | +0.1% | 0.53% | +15.2% |
Q4 2019 | $2,660,000 | -27.5% | 150,000 | -36.6% | 0.46% | -34.1% |
Q3 2019 | $3,669,000 | -9.7% | 236,540 | 0.0% | 0.70% | -11.0% |
Q2 2019 | $4,064,000 | +6.7% | 236,540 | 0.0% | 0.79% | -0.8% |
Q1 2019 | $3,808,000 | +10.0% | 236,540 | 0.0% | 0.79% | -5.6% |
Q4 2018 | $3,461,000 | – | 236,540 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |